Related Experiment Video

Updated: Jun 13, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.6K

Promoting medication compliance in epileptic children: a cross sectional survey

Lijuan Zhang1, Ping Li2, Junping He1

  • 1Department of Neurosurgery, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu province, China.

BMC Pediatrics
|September 14, 2024
PubMed

Insights

Medication non-compliance in pediatric epilepsy is common, affecting over 30% of children. Parental education, income, number of medications, and epilepsy knowledge significantly impact adherence, necessitating targeted interventions.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacy
  • Public Health

Background:

  • Medication compliance is critical for managing epilepsy in children.
  • Suboptimal adherence negatively impacts treatment outcomes and prognosis.
  • Understanding factors influencing compliance is essential for effective pediatric epilepsy care.

Purpose of the Study:

  • To identify determinants of medication non-compliance in pediatric epilepsy patients.
  • To develop and validate a predictive model for identifying children at risk of non-compliance.
  • To inform clinical strategies for improving medication adherence in this population.

Main Methods:

  • A cohort of 168 children with epilepsy was analyzed.
  • Demographic data and medication compliance were assessed.
  • A predictive model was developed and its performance evaluated using ROC curve analysis.

Main Results:

  • The medication non-compliance rate was 32.74%.
  • Parental education, household income, number of medications, and epilepsy knowledge were significant predictors of non-compliance (p < 0.05).
  • The predictive model demonstrated good discriminative ability (AUC = 0.713).

Conclusions:

  • Medication compliance in pediatric epilepsy is influenced by socioeconomic and knowledge-based factors.
  • A validated predictive model can aid in early identification of non-compliant patients.
  • The findings support the development of targeted interventions to improve medication adherence.
Abstract

Keywords:
CareChildrenComplianceEpilepsyNursingTreatment

More Related Videos

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.6K
Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

2.8K

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
40
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
271
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
788
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
394